Evidence Hub

Artificial Intelligence in Rheumatology: Clinical Applications in Rheumatoid Arthritis, Osteoarthritis, and Systemic Lupus Erythematosus

Aldhuaina K, Gupta D, Bashir U, Nnap LM, Rawat A, Dolphin J, Sultana R, Cai LY et al.

Cureus, 2025

Abstract

Artificial intelligence (AI) has emerged as a transformative force in rheumatology, offering novel diagnostic, predictive, and therapeutic capabilities across chronic inflammatory and autoimmune diseases. This narrative review specifically focuses on rheumatoid arthritis (RA), osteoarthritis (OA), and systemic lupus erythematosus (SLE), where AI applications have been most extensively studied and show the greatest clinical translational potential. In RA, AI applications span early diagnosis via imaging-based models, identification of novel biomarkers through multi-omics integration, and prediction of disease progression and therapeutic response using deep learning algorithms. For OA, AI enhances radiographic interpretation, develops personalized risk prediction models, and enables individualized rehabilitation through wearable and biomechanical data analysis. In SLE, AI aids in biomarker discovery, disease activity monitoring via biosensors, and flare prediction using federated machine learning, with promising applications in high-risk groups. Despite these advances, challenges persist regarding data quality, algorithmic bias, limited explainability, and lack of real-world validation. Ethical considerations surrounding data privacy and equitable access must be addressed to ensure responsible deployment. The review underscores the importance of hybrid human-AI collaboration, integration into electronic health records, and interdisciplinary cooperation to unlock AI's full…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free